» Articles » PMID: 8232800

Pituitary Adenomas with Invasion of the Cavernous Sinus Space: a Magnetic Resonance Imaging Classification Compared with Surgical Findings

Overview
Journal Neurosurgery
Specialty Neurosurgery
Date 1993 Oct 1
PMID 8232800
Citations 480
Authors
Affiliations
Soon will be listed here.
Abstract

We present 25 pituitary adenomas that were confirmed surgically to have invaded the cavernous sinus space. The surgical results are compared with the preoperative magnetic resonance imaging findings. For comparable radiological criteria, we classified parasellar growth into five grades. This proposed classification is based on coronal sections of unenhanced and gadolinium diethylene-triamine-pentaacetic acid enhanced magnetic resonance imaging scans, with the readily detectable internal carotid artery serving as the radiological landmark. The anatomical, radiological, and surgical conditions of each grade are considered. Grades 0, 1, 2, and 3 are distinguished from each other by a medial tangent, the intercarotid line--through the cross-sectional centers--and a lateral tangent on the intra- and supracavernous internal carotid arteries. Grade 0 represents the normal condition, and Grade 4 corresponds to the total encasement of the intracavernous carotid artery. According to this classification, surgically proven invasion of the cavernous sinus space was present in all Grade 4 and Grade 3 cases and in all but one of the Grade 2 cases; no invasion was present in Grade 0 and Grade 1 cases. Therefore, the critical area where invasion of the cavernous sinus space becomes very likely and can be proven surgically is located between the intercarotid line and the lateral tangent, which is represented by our Grade 2. We also measured tumor growth rates, using the monoclonal antibody KI-67, which shows a statistically higher proliferation rate (P < 0.001) in adenomas with surgically observed invasion into the cavernous sinus space, as compared with noninvasive adenomas.

Citing Articles

Good response rates and predictors during the first year of cabergoline treatment in large invasive prolactinomas.

Bostan H, Ucan B, Duger H, Hepsen S, Kayihan S, Dilli A Pituitary. 2025; 28(2):38.

PMID: 40064718 DOI: 10.1007/s11102-025-01512-5.


Is Knosp enough? A novel classification for Acromegaly: a retrospective analysis of cure rates and outcome predictors in a large tertiary centre.

Fayez F, Abougamil A, Vitulli F, Knight J, Syrris C, Genel O Acta Neurochir (Wien). 2025; 167(1):61.

PMID: 40055188 PMC: 11889057. DOI: 10.1007/s00701-025-06477-9.


Relationship between MRI features and HIF-1α, GLUT1 and Ki-67 expression in pituitary adenoma with cystic degeneration.

Zhang F, Pan Z, Wu J, Huang Y BMC Med Imaging. 2025; 25(1):76.

PMID: 40050749 PMC: 11887064. DOI: 10.1186/s12880-025-01574-8.


A Narrative Review of Surgery for Prolactinomas: Considerations and Controversies.

Mann J, Starreveld Y, Riva-Cambrin J, Lithgow K J Clin Med. 2025; 14(4).

PMID: 40004619 PMC: 11856391. DOI: 10.3390/jcm14041089.


Does a Transcriptionally Active HPV Infection Affect the Invasiveness of Pituitary Neuroendocrine Tumors? A Case Series Study of 60 Patients in Krakow, Poland.

Krzentowska A, Biesaga B, Czepko R, Adamek D, Merklinger-Gruchala A, Golkowski F Cancers (Basel). 2025; 17(4).

PMID: 40002278 PMC: 11853133. DOI: 10.3390/cancers17040684.